Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Boehringer Ingelheim accepts DCR-LIV2 as development candidate under Dicerna agreement

May 26, 2021

CARB-X grant supports Basilea's development of small-molecule inhibitors of DXR

May 20, 2021

Dr. Reddy's licenses anti-BCMA CAR T PRG-1801 for India

May 14, 2021

Checkmate and Regeneron enter agreement to evaluate vidutolimod plus cemiplimab

May 11, 2021

DarwinHealth and Bristol Myers Squibb establish Novel Cancer Target Initiative

May 7, 2021

XBiotech and INSERM collaborate on phase II/III trial of XB-2001

May 4, 2021

Cereno and University of Michigan collaborate on preclinical development of CS-585

April 30, 2021

ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC

April 29, 2021

Collaboration promotes new antimalarial drug development

April 26, 2021

Zenith agrees with Astellas to study ZEN-3694 with enzalutamide in metastatic CRPC

April 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...